With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Ltd. is advancing its commitment to sustainable weight management among Thais through the launch of the 'From My Weight to My Heart' campaign, aimed at reducing the risk of cardiovascular diseases and ...

Novo Nordisk, the global pharmaceutical leader headquartered in Denmark, has launched a major initiative to combat Thailand's growing obesity crisis, where more than 40% of the population is now ...

Blood and urine tests might be able to reveal how much of your diet is made up of industrially produced foods, a new study ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Novo Nordisk is teaming up with Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.